glutamic acid has been researched along with losartan in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Meanwell, NA | 1 |
| Averill, DB; Ferrario, CM; Khosla, MC; Tsuchihashi, T | 1 |
| Averill, DB; Barnes, KL; Fow, JE | 1 |
| Barnes, KL; Ferrario, CM; McQueeney, AJ | 1 |
| Ferguson, AV; Sun, K | 1 |
| Berrino, L; D'Amico, M; Maione, S; Oliva, P; Pizzirusso, A; Rossi, F | 1 |
| Hagiwara, Y; Kubo, T | 2 |
| Ferguson, P; Grammatopoulos, T; Jing, G; Schelman, W; Weyhenmeyer, J | 1 |
| Hagiwara, Y; Kubo, T; Ohi, M | 1 |
| Colombari, DS; Colombari, E; De Luca, LA; De Paula, PM; Menani, JV; Vieira, AA | 1 |
| Akaike, A; Hongo, H; Kihara, T; Niidome, T; Sugimoto, H; Wu, X | 1 |
| Huber, DA; Schreihofer, AM | 1 |
| Liu, X; Llewellyn, T; Patel, KP; Xu, B; Zheng, H | 1 |
| Kang, YM; Qi, J; Qin, DN; Su, Q; Suo, YP; Yang, Q; Yu, XJ; Yue, LY; Zhang, DM; Zhu, GQ | 1 |
| Jia, R; Liu, B; Liu, Q; Wang, T; Yu, H | 1 |
| Chen, WS; Cui, W; Fan, XY; Gao, HL; Jia, LL; Kang, YM; Liu, JJ; Liu, KL; Shi, XL; Yu, XJ; Zhang, Y; Zhu, GQ | 1 |
18 other study(ies) available for glutamic acid and losartan
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synopsis of some recent tactical application of bioisosteres in drug design.
Topics: Cytochrome P-450 Enzyme System; Drug Design | 2011 |
Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Glutamic Acid; Hemodynamics; Imidazoles; Losartan; Male; Medulla Oblongata; Microinjections; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Sympathetic Nervous System; Tetrazoles | 1994 |
Mechanisms of angiotensin-induced hypotension and bradycardia in the medial solitary tract nucleus.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Bradycardia; Cardiovascular System; Glutamates; Glutamic Acid; Hypotension; Imidazoles; Losartan; Male; Medulla Oblongata; Microinjections; Oligopeptides; Rats; Rats, Sprague-Dawley; Tetrazoles; Vagus Nerve | 1994 |
Receptor subtype that mediates the neuronal effects of angiotensin II in the rat dorsal medulla.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Electrophysiology; Glutamates; Glutamic Acid; Imidazoles; In Vitro Techniques; Losartan; Medulla Oblongata; Neurons; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles | 1993 |
Angiotensin II and glutamate influence area postrema neurons in rat brain slices.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Brain; Cerebrospinal Fluid; Electrophysiology; Excitatory Amino Acids; Glutamic Acid; Imidazoles; Losartan; Male; Medulla Oblongata; Neurons; Rats; Rats, Sprague-Dawley; Tetrazoles; Vasoconstrictor Agents | 1996 |
Role of vasopressin on excitatory amino acids mediated pressor responses in the periaqueductal gray area.
Topics: Acetylcholine; Animals; Arginine Vasopressin; Blood Pressure; Ganglionic Blockers; Glutamic Acid; Hexamethonium; Losartan; Male; N-Methylaspartate; Periaqueductal Gray; Rats; Rats, Brattleboro | 1998 |
Tonic angiotensinergic inputs to neurons in the anterior hypothalamic area of rats.
Topics: Acetylcholine; Action Potentials; Adrenergic alpha-Agonists; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Anterior Hypothalamic Nucleus; Anti-Arrhythmia Agents; Captopril; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Imidazoles; Losartan; Male; Muscarinic Antagonists; Neurons; Phenylephrine; Pyridines; Rats; Rats, Wistar; Scopolamine | 2004 |
Inhibitory effects of angiotensin on NMDA-induced cytotoxicity in primary neuronal cultures.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Brain; Cells, Cultured; Dose-Response Relationship, Drug; Glutamic Acid; In Situ Nick-End Labeling; Losartan; Mice; N-Methylaspartate; Neurons; Neuroprotective Agents | 2004 |
Cholinergic stimulation in the lateral septal area activates anterior hypothalamic area neurons via excitatory amino acid receptors in rats.
Topics: Acetylcholine; Action Potentials; Angiotensin II Type 1 Receptor Blockers; Animals; Anterior Hypothalamic Nucleus; Carbachol; Cholinergic Agonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamic Acid; Kynurenic Acid; Losartan; Male; Microinjections; Muscarinic Antagonists; Neural Pathways; Neurons; Rats; Rats, Wistar; Receptors, Glutamate; Scopolamine; Septum of Brain | 2005 |
Cholinergic stimulation in the posterior hypothalamic nucleus activates angiotensin II-sensitive neurons in the anterior hypothalamic area of rats.
Topics: Acetylcholine; Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anterior Hypothalamic Nucleus; Carbachol; Cholinergic Agonists; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Hypothalamus, Posterior; Losartan; Male; Microinjections; Muscarinic Antagonists; Neurons; Physostigmine; Rats; Rats, Wistar; Scopolamine; Time Factors | 2005 |
Importance of angiotensinergic mechanisms for the pressor response to l-glutamate into the rostral ventrolateral medulla.
Topics: Angiotensin II; Angiotensins; Animals; Anti-Arrhythmia Agents; Autonomic Pathways; Blood Pressure; Cardiovascular Physiological Phenomena; Glutamic Acid; Losartan; Male; Medulla Oblongata; Naphthyridines; Rats; Rats, Sprague-Dawley; Reticular Formation; Sympathetic Nervous System; Vasoconstriction | 2010 |
Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Astrocytes; Benzimidazoles; Benzoates; Biphenyl Compounds; Cell Death; Coculture Techniques; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glucose; Glutamic Acid; Imidazoles; Losartan; Neurons; Nitric Oxide; Oxygen; Rats; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Telmisartan | 2010 |
Altered regulation of the rostral ventrolateral medulla in hypertensive obese Zucker rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Brain Stem; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Heart Rate; Hypertension; Losartan; Medulla Oblongata; Microinjections; Muscle Tonus; Muscle, Smooth, Vascular; Obesity; Rats; Rats, Zucker; Receptors, GABA-A; Splanchnic Circulation; Sympathetic Nervous System | 2011 |
Median preoptic nucleus and subfornical organ drive renal sympathetic nerve activity via a glutamatergic mechanism within the paraventricular nucleus.
Topics: 2-Amino-5-phosphonovalerate; Angiotensin II Type 1 Receptor Blockers; Animals; Bicuculline; Blood Pressure; Excitatory Amino Acid Antagonists; GABA-A Receptor Antagonists; Glutamic Acid; Heart Rate; Kidney; Losartan; Male; N-Methylaspartate; Neurons; Paraventricular Hypothalamic Nucleus; Preoptic Area; Rats; Rats, Sprague-Dawley; Subfornical Organ; Sympathetic Nervous System | 2012 |
Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines.
Topics: Angiotensin II; Animals; Cardiomegaly; Chemokine CCL2; Enalaprilat; gamma-Aminobutyric Acid; Glutamic Acid; Heart; Hypertension; Interleukin-10; Interleukin-1beta; Interleukin-6; Kidney; Losartan; Male; Neurotransmitter Agents; Norepinephrine; Organ Size; Paraventricular Hypothalamic Nucleus; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2014 |
Interaction between interleukin-1 beta and angiotensin II receptor 1 in hypothalamic paraventricular nucleus contributes to progression of heart failure.
Topics: Animals; Corticotropin-Releasing Hormone; Disease Models, Animal; Disease Progression; gamma-Aminobutyric Acid; Glutamic Acid; Heart Failure; Interleukin-1beta; Losartan; Male; Norepinephrine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1 | 2014 |
Exercise training attenuates renovascular hypertension partly via RAS- ROS- glutamate pathway in the hypothalamic paraventricular nucleus.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Glutamic Acid; Hypertension, Renovascular; Losartan; Male; NADPH Oxidase 2; NADPH Oxidases; Paraventricular Hypothalamic Nucleus; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Glutamate; Renin-Angiotensin System; Sedentary Behavior; Signal Transduction; Superoxide Dismutase | 2016 |